Drug Patent Expirations for Nov 17, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

CYANOKIT (hydroxocobalamin)
Serb Sa
Patent number: 5,834,448
Expiration Date: Nov 14, 2016

FANAPT (iloperidone)
Vanda Pharms Inc
Patent number: RE 39,198
Expiration Date: Nov 15, 2016

EPIVIR-HBV (lamivudine)
Glaxosmithkline
Patent number: 5,905,082
Expiration Date: Nov 18, 2016

TRIZIVIR (abacavir sulfate; lamivudine; zidovudine)
Viiv Hlthcare
Patent number: 5,905,082
Expiration Date: Nov 18, 2016

TRIUMEQ (abacavir sulfate; dolutegravir sodium; lamivudine)
Viiv Hlthcare
Patent number: 5,905,082
Expiration Date: Nov 18, 2016

EPZICOM (abacavir sulfate; lamivudine)
Viiv Hlthcare
Patent number: 5,905,082
Expiration Date: Nov 18, 2016

COMBIVIR (lamivudine; zidovudine)
Viiv Hlthcare
Patent number: 5,905,082
Expiration Date: Nov 18, 2016

EPIVIR (lamivudine)
Viiv Hlthcare
Patent number: 5,905,082
Expiration Date: Nov 18, 2016

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial

Click here for reuse options!
Copyright 2016 Biotechblog

Leave a Reply

%d bloggers like this: